The purpose of this article is to provide common data elements (CDEs) for rodent (mouse and rat) epilepsy models in the area of physiology, to facilitate an understanding of the critical importance of assessing various physiologic parameters in preclinical epilepsy research. While working on these CDEs we came to realize that the measurement of physiologic data in epilepsy research in rodents is very rare (except for electroencephalography [EEG] monitoring). Although blood pressure, heart rate, and temperature measurements as indicators of general health are standard procedures in people with epilepsy, the measurement of various basic physiologic parameters that are good indicators of the general health status of the animals is rarely used in preclinical epilepsy research. We realize that implementation of these types of measurements comes with additional costs; however, we hope that the proposed experimental recommendations and forms may inspire researchers to include these types of physiologic measurements in their future experimental design when possible and to use these forms accordingly.
Here we present a companion paper to standardized data acquisition forms related to the measurements of general health and several common physiologic parameters. These are aimed at enabling consistent data collection across different experiments and different laboratories.
We aimed to collect numerous possibilities to measure various physiological aspects reflecting the health status of the animals. The provided protocols are example experimental methods for obtaining physiologic parameters in rats, mice, or both. This list is meant to help researchers to decide what type of measurement would be useful according to the type of epilepsy or seizure studied and to encourage the use of case report forms (CRFs) presented here in order to standardize future experiments that involve physiologic measurements. While assessing the general health status of the animals will always be informative and important, monitoring of respiratory or cardiovascular parameters is not specifically needed in all models studied but is strongly recommended in models of sudden unexpected death in epilepsy (SUDEP). Likewise, although body core temperature is easy to monitor and will provide useful information, brain temperature is considered similar to body core temperature and most often is not specifically needed and not measured. In addition, it must be noted that many of the techniques reported in this article are invasive and it is critical to weigh the benefit linked to any physiologic measurement versus the additional stress imposed on the animal by anesthesia and surgery.
Methods
The Physiology Working Group consisted of 8 experienced preclinical epilepsy researchers who developed CDEs for 6 physiology modules (see following paragraphs).
The CDEs are organized around the following modules: (1) General health status, (2) Temperature, (3) Respiration, (4) Heart rate, (5) Blood pressure, and (6) Blood sampling and testing.
The forms are constructed in analogy to previous preclinical CDEs by the National Institute of Neurological Disorders and Stroke (NINDS) for traumatic brain injury research. 1 CDEs generated by the EPITARGET consortium (Targets and Biomarkers for Antiepileptogenesis) served as useful templates for our TASK3 Physiology working group. 2 The proposed recommendations originate mostly from previously published methods used for rodent physiology research.
The CDEs presented here apply to adult rodents, rats or mice, and are not readily applicable to immature animals, which will need specific CDEs taking into account their size, ongoing acquisition of specific functions, 3 as well as some metabolic specificities such as the dependence on ketone bodies for their brain energy metabolism. 4 
Results
For each physiology module (A-F) we provide a rationale and an overview of the elements that are included in the corresponding CRFs. The CDE and CRF modules linked to this article can be downloaded and can be found as supplementary tables in a zip folder (Appendix S1).
Assessment of the general health status
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Rationale
General health status is assessed to monitor an animal's well-being during the experiment, including the effects of all procedures. Evaluation of the health status is an essential part of the physiology assessment. It is easy to do and provides readily available information about the general wellbeing of the animal to a trained observer. It will help understanding of the immediate consequences of the procedures used on the animal's basal physiology parameters and will allow researchers to rapidly decide whether the degree of suffering of the animal is acceptable. General health status is assessed by observational criteria based on the evaluation of animal behavior and appearance in the housing environment and during routine handling. The general appearance of the animals is a reliable indicator of general health and well-being. Physical examination easily provides information on body condition and the degree of hydration. With the exception of testing for pathogens, it is noninvasive. Because evaluation is based on subjective criteria this should be performed by highly trained personnel. The explanations below are provided to facilitate data acquisition using the CRF shown in Fig. 1 .
Measurement of physiologic parameters for assessing general health status
All basal measurements of general health status can be performed in awake, freely moving animals.
Hair; Coat and skin Diarrhea; Vomiting Figure 1 . Assessment of the general health status of adult rodent CRF module Epilepsia Open ILAE Body weight should be evaluated regularly with a frequency relevant to experimental design. Body weight can be evaluated in 2 ways: (1) Percent loss of body weight is measured as a percentage decline from initial (before procedure) weight, and (2) body weight is compared with that of untreated animals. 5 To avoid critical weight loss and dehydration, the animals are encouraged to eat by the use of moistened food pellets, gels and treats, and liquid baby food, which can be placed on the cage floor or even given individually. In addition, subcutaneous fluids (saline or sucrose solutions) are sometimes injected after status epilepticus (SE) when animals are too weak to eat and drink. 6 Body condition score (BCS) is an effective, noninvasive method of health assessment in rodents. It is performed by observing and palpating the flesh over the bony protuberances of the hips and lumbar spine. It is rated on the following scale: 1, emaciated; 2, under-conditioned; 3, wellconditioned; 4, over-conditioned; 5, obese.
5,7
General appearance is evaluated by observation of animal behavior in the home cage or during handling by noting the presence or absence of the following features 5 :
• Hair, coat, and skin are evaluated by the presence or absence of hair loss, ruffled or dirty coat, open scratches, or rash. 8 Bowel and gastrointestinal function are evaluated by the presence or absence or number of fecal pellets, fecal staining on the tail, constipation, diarrhea, or recto-anal prolapse, which is an intussusception of the rectum. Genitals are evaluated by the presence of testicular or other abnormalities, such as penile prolapse. 9 Throat and lung function is evaluated by the presence or absence of discharge and dyspnea.
Eyes are evaluated by the presence or absence of reddish porphyrin staining around the eye.
Ear dysfunction is diagnosed on the basis of circling behavior and head tilt.
Teeth problems are evaluated on the basis of teeth overgrowth, breakage, or malocclusion.
Gait is characterized by the following scoring starting from normal and ending with severe dysfunction 8, 10 :
• The following information is provided to facilitate the use of the CRF in Fig. 2 for data acquisition. The CRF may be modified according to the choices made for obtaining data, since there are options, as discussed below.
Rationale
Body temperature is a basal indicator of the animal's health. If the experimenter decides to include this physiologic parameter in the experimental design, it is recommended that the body temperature is monitored in every single animal before the onset of a procedure. This allows confirmation of the health status of the animals and helps to avoid the use of animals whose body temperature is not in the physiologic range. As an example, the induction of SE by pilocarpine leads in animals to high fever, and monitoring seizure-induced changes could help our understanding of why animals do or do not survive the SE phase, and whether mortality might be, at least in part, related to temperature elevation. 17 Febrile seizures are common in young children aged 6 months to 6 years. 18 Most febrile seizures are benign, but complex, prolonged febrile seizures lasting over 10-20 minutes are associated with a risk of developing subsequent epilepsy. 19 Therefore, animal models for studying characteristics and consequences of febrile seizures have been developed and studied.
Body temperature can be measured in awake animals to follow changes in temperature over time, or during anesthesia (e.g., during surgery or imaging) to keep body temperature within a physiologic range. 20 Because low body temperature or head cooling can influence the extent of brain damage, it is important to report body temperature if an intervention is likely to induce changes. Moreover, failure to measure body temperature can confound the interpretation of experiments, as it may not be known whether, for example, extreme change in body temperature contributed to an outcome, or whether an intervention (e.g., an anti-inflammatory agent) had an indirect impact by changing body temperature, rather by another mechanism of action. In experimental epilepsy models, body temperature increases during SE. 17 Furthermore, the circadian rhythm of temperature is altered in epileptic rats, which is associated with regional hypothalamic neuronal loss. 21 Rats that were cooled during SE had a significantly lower body temperature compared to cooled control rats or non-SE rats, 22 indicating a disturbed temperature homeostasis during SE. Hyperthermia during an insult or injury increases the risk of developing epilepsy, as has been demonstrated with immature rodents when using the febrile seizure model. 23, 24 Inducing hypothermia during SE in experimental epilepsy models had anticonvulsant and neuroprotective effects (for review see Motamedi et al. 25 ). Regarding the influence of (brain) temperature on seizure outcome, it may be interesting to evaluate the potential effects of drugs on (brain) temperature.
Measurement of body temperature
All the procedures described below can be used in awake animals, but some of them necessitate a prior surgical intervention to insert the probe or the sensor that will later record the body or brain temperature.
Equipment: Rectal probe, infrared probe, or implanted radiotelemetric core body or brain temperature sensor.
Procedure: Prepare anesthesia (e.g., isoflurane anesthesia) or perform measurements in awake animals. Temperature can be measured using one of the following more or less invasive methods:
Noninvasive methods
• Feedback-regulated heating pad. Indicate whether used or not.
• Rectal probe. Apply a bit of lubricant on the probe before inserting.
26
• Infrared probe (e.g., Braintree Scientific, Braintree, MA, USA). Measure the cutaneous temperature on paw or tail. 23 Invasive methods
• Implanted radiotelemetric body core temperature sensor (e.g., Data Sciences International, St Paul, MN, USA). Implant sensor under anesthesia via a small abdominal incision. Allow animals to recover for at least 4 days before further experimentation to allow circadian rhythms to normalize.
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• Implanted radiotelemetric brain temperature sensor (e.g., mini-mitter, Starr Life Sciences, Oakmont, PA, USA). Implant sensor under anesthesia in the brain using preselected coordinates using the Paxinos atlas. For more details on the procedure see Appendix S2. Allow animals to recover for at least 4 days before further experimentation to allow circadian rhythms to normalize (see Meyer et al. 26 and DeBow and Colbourne 28 ).
Analysis and interpretation
Parameters that can be determined are core body temperature (°C) and brain temperature (°C). Normal body temperature for rats is between 37 and 38°C and for mice is between 36.5 and 38°C. Brain temperature is usually considered a "central" temperature, and in the absence of intracranial pathology, changes in brain temperature can be estimated by measuring changes in body core temperature. However, in cases of severe cerebral injury, the estimates yielded by such measurements may be inaccurate. A positive brain-body temperature gradient (brain temperature > body temperature) was observed in freely moving rats 29 and mice. 30 In anesthetized states, possibly due to the suppression of metabolic heat production by the anesthetic agent as well as effective heat exchange with the environment through the head, a negative brain-body temperature gradient (brain temperature < body temperature) has been observed in rats. In awake freely moving rats, temperature in hippocampus and piriform cortex can decrease 0.5°C over a 1 h period of sleep and quiet wakefulness, and then increase 1.5°C when the rat is actively exploring. 31 
Respiration
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Rationale
Respiratory parameters (for data acquisition, see Fig. 3 ) are generally measured under anesthesia (e.g., during surgery or imaging), in spontaneously breathing animals, or ventilated animals, to monitor the physiologic range of these parameters. 20, 32 Although respiratory parameters are not often measured in awake animals, it may also be important to assess respiratory parameters in experimental epilepsy models, since hypoxia may occur as a result of SE. 33 Hypoxia increases the risk of developing epilepsy, as has been demonstrated in the neonatal hypoxia model. 34, 35 Furthermore, under hypoxic conditions, SE-induced neuronal damage is more severe. 36, 37 In contrast, hyperoxia did not lead to additional neuronal death. 38 
Assessment of respiratory function
Equipment: Mouth mask, endotracheal tube, pulse oximeter, respiration sensor, intravenous/intra-arterial cannulas, plethysmograph, pressure sensitive catheter.
Procedure: Prepare anesthesia (for example, ketamine rat 40-100 mg/kg; mouse 80-120 mg/kg and xylazine rat 5-13 mg/kg; mouse 10-16 mg/kg) or perform measurements in awake animals.
Depending on the type of experiment (anesthetized vs awake animals) respiratory parameters can be measured using the following methods:
Noninvasive methods:
• Mouth mask. Expired CO 2 can be measured using a calibrated device that is connected to the tube.
• Pulse oximeter. Apply securely on the animal's hindpaw.
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• Respiration sensor (e.g., BioVet, m2 m Imaging Corp., Cleveland, OH, USA). Fix the respiration sensor under the chest of the animal to measure the respiration movement of the chest. 40 Implanted movement sensors can also be used for measuring breathing patterns such as the movement sensor 230 (Siemens) using a piezo crystal sensor. 41 • Unrestrained whole body plethysmography (UWBP) can be used in epilepsy research to perform traditional measurements on pulmonary function: breath frequency, tidal volume, minute ventilation, inspiratory time, expiratory time, and so on. UWBP is an adequate technique for assessing those parameters, especially when also accounting for the animal's weight, body temperature, ambient temperature, relative humidity, atmospheric pressure, flow of gas/air into the recording chamber, flow of gas/air out of the chamber, and the activity/behavioral state (resting, moving, grooming, sniffing, eating, drinking, etc., which aid data interpretation) of the animal. 42 Despite some limitations, as discussed by Bates et al., 43 UWBP is considered valid if performed correctly and modeled after the Drorbaugh-and-Fenn formula. 44 In this commonly used method, animals are not restrained, but movement is restricted by the use of a relatively small chamber to keep the volume small with respect to the animal's size. This allows for measurements in freely behaving animals attached to tethers for EEG, electromyography (EMG), and electrocardiography (ECG) measurements. 45 Because the data depend on measuring pressure waves, movements associated with seizures during the ictal phase might impair the breathing measurements. The method is suitable for measuring breathing during the pre-and postictal phases and allows for successful assessment of the effects of a variety of variables such as sleep state, time of day, sex, and genetic, optogenetic, and pharmacologic manipulations in a number of seizure/epilepsy models. [45] [46] [47] For more details on the procedure see Appendix S2 and Ref. 32. • Head-out restrained plethysmography. Prior to the measurements, the animals are trained for 5 days during increasing time periods (from 2-3 min up to about 30 min) to get accustomed to the plethysmograph. For lung function measurements, the animals are placed in body plethysmographs while the head of each animal protrudes through a neck collar of a dental latex dam into a head exposure chamber. This can be adapted for use with seizure induction in head-fixed preparations (see Zhan et al., 48 for example). For more details see Appendix S2 and Refs. 32, 45-48.
• Forced oscillation technique (FOT). Measurements are typically obtained by analyzing pressure and volume signals acquired in reaction to a predefined, small amplitude, oscillatory airflow waveform (also referred to as perturbation or input signal) applied at the subject's airway opening. In its simplest form, an FOT perturbation would be a single sinusoidal waveform at a well-defined frequency. More complex perturbations typically consist of a superposition of a selection of specific (mutually prime) frequency waveforms covering a broad spectrum. The decomposition of the multi-frequency input and output signals into their constituents using the Fourier transform allows the calculation of respiratory system input impedance (abbreviated Zrs), that is, the transfer function between the input and output signals, at every frequency included in the perturbation. Therefore, FOT permits the simultaneous assessment of respiratory mechanics over a range of frequencies in a single maneuver. Fitting advanced mathematical models (e.g., the Constant Phase Model) to the impedance data then permits a partitioning of the response into the airway (central and peripheral) and parenchymal lung tissue dependent parameters. Because many factors influencing the physiologic response (e.g., breathing frequency, tidal volume, lung volume, upper airways, spontaneous breathing efforts, and timing of measurements) are controlled and standardized by the measurement system and experimental procedures, the technique can generate precise and reproducible measurements provided that it is performed correctly. 49 Invasive methods:
• Chronic implantation of a thermistor probe into the hollow space located above the anterior portion of the nasal cavity. This probe does not penetrate any soft epithelial tissues and allows recording of the respiratory rhythm in awake mice with high precision. It does not damage or irritate the nasal epithelium and is compatible with studies in freely moving animals, as in seizure or epilepsy models. 50 • Endotracheal tube. When the animal is anesthetized, spray lidocaine on the endotracheal tube and intubate the animal using transillumination. For more details see Appendix S2 and Ref. 51.
• Tracheotomy. A small incision (1.
• Pressure-sensitive catheter. The pressure-sensitive catheter is surgically implanted and resides below the serosal layer of the esophagus to enable direct measurement of sub-pleural pressure. Measurements are performed by telemetry.
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• Intravenous or intra-arterial cannulas. See CRF module and forms for blood testing.
Analysis and interpretation
Respiratory parameters that can be determined:
• Heart rate and electrocardiography (ECG)
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Rationale
There has been a renewed interest in investigating the impact of seizures and epilepsy on cardiovascular and autonomic function in preclinical models in order to try to better understand the pathophysiologic mechanisms of SUDEP. 54, 55 Studies in transgenic mouse models have identified genetic defects that lead to seizures, cardiac arrhythmias, and sudden death. [56] [57] [58] Genetic defects include those encoding for ion channels expressed in both heart and brain as well as neuronal-expressed proteins that impact vagus nerve function. 59 High rates of SUDEP are found in Dravet syndrome, a severe infantile epilepsy syndrome due to a mutation in the SCN1A sodium channel gene. 60 61 Studies have also demonstrated acquired cardiac conduction defects in epileptic rodents, but the relationship to SUDEP is not clear. 62 Assessment of cardiac parameters and function Specific Methods:
• Prepare anesthesia (for example, isoflurane anesthesia) or perform measurements in awake animals.
Depending on the type of experiment (anesthetized vs awake animals, short term vs long term recording) heart rate can be measured using the following methods (see Ho et al. 63 for review): Techniques usable in awake animals:
• External heart rate sensor. Place heart rate sensor under the chest of the anesthetized animal and position the sensor until a proper heart rate signal is obtained. 64 • Noninvasive platform devices (ECGenie, mouse specifics, Framingham, MA, USA). The animal is placed on a platform with 3 paw-sized gelled electrodes (e.g., M1605A Snap, Hewlett-Packard, Andover, MA, USA) and the paws are gently positioned over the pads. The animal can be anesthetized, restrained, or acclimated to the platform. The electrodes are connected to a bioamplifier, A/D acquisition system, and analyzed as described in the following text. 65 • Electrocardiography (or ECG) electrodes (e.g., BioVet, m2 m Imaging Corp., Cleveland, OH, USA). Shave and clean the skin surfaces for electrode location if needed. Subdermal needle electrodes, electrode pads, or surface electrodes (with conductance gel) can be used. Position the ECG electrodes on the skin, for example, left and right from the heart. Position the ground electrode on the hind leg. The leads are then connected to a bioamplifier or heart rate sensor. 20 • Implanted ECG electrodes. Rats should be anesthetized and stainless-steel spring electrodes covered with polyurethane tubing, except for the final 5-8 mm, are implanted just caudal to the diaphragm and in the mediastinum. For additional details see Appendix S2 and Ref. 51. • Implanted ECG telemetry devices. Leads are implanted similarly to above, with a telemetry device (e.g., Data Sciences International, Respironics, Mini-mitter, etc.) implanted into the peritoneum as per the manufacturer's protocol. The signals are sampled via a telemetry receiver situated under the animal's cage. Five to 7 days of recovery is recommended before recording. These systems are most suitable for chronic, long-term recordings in freely behaving animals. 66 Qualitative, morphologic assessment of ECG rhythm:
• Amplification, sampling, and analysis of ECG signals.
For internal or external wired ECG recordings, the ECG signals are amplified and filtered using a bioamplifier (e.g., 0.5-100 Hz bandpass, Model 12C 16OS, Grass Technologies, Quincy, MA, USA). Signals are sampled at 1000 Hz (e.g. Power Lab/8SP; AD Instruments, Melbourne, Australia). Numerous software packages exist to measure heart rate automatically in rodents (e.g., EzCG ECG analysis, mouse specifics, inc; AcqKnowledge, Biopac, Goleta, CA, USA; Chart 5, AD Instruments). It is important to note that heart rate should be measured from the interval between R peaks on the ECG. Poor signal-tonoise can complicate ECG monitoring, especially in freely behaving, epileptic rats. Data selected for heart rate variability (HRV) analysis must be artifact free and importantly, arrhythmia free. Seizure-induced arrhythmia may prevent accurate detection of the R peaks and heart rate measures. Sleep-wake states influence HRV, as do stress and seizures; thus it is critical to note the behavioral conditions during which these endpoints are measured. In addition, the signal must be assessed qualitatively for rhythm disturbances in addition to the qualitative measures of heart rate. 67, 68 • Evaluate the QRS complex. If the QRS complex appears of normal height and duration, then the initiating impulse originates above the A-V node. When the QRS complex appears wide and bizarre, the impulse initiating that complex originates at an ectopic pacemaker site within the ventricles. 69 • Evaluate the relationship between the P waves and QRS.
On a normal ECG, there should be a P wave for every QRS, with a consistent P-R interval. Prolonged P-R intervals indicate a conduction delay through the A-V node. Short P-R intervals, where the P wave is positioned very close to the QRS complex, indicate that the impulse was generated around the A-V node. 70 • Evaluate the T wave. With complicated arrhythmias, it may be difficult to discern a P wave from a T wave. A T wave will always follow every QRS complex, but the same is not true for P waves, which may be buried in the complex or missing from the complex altogether. 69, 71 Parameters that can be determined:
• Frequency (heart rate): often expressed as beats/minute In one series of 5 unrestrained, awake Wistar rats, the mean RMSSD was 5.18 AE 1.16 msec. 72 In a study of HRV in C57BL/6J mice, the mean RMSSD was 6.1 AE 1.5 msec. 73 RMSSD is commonly reported as a natural log of the measured values (i.e., lnRMSDD).
• Q-T interval correction. Calculating the rate-corrected QT interval (QTc) is typically performed using Bazett's formula, QTc = QT/RR 1/2 , for rodents.
Expected results for heart rate Basal heart rate varies by species, strain, and time of day. For example, in mice, mean heart rates between 500 and 650 bpm have been reported for C57/B6, FVB, and 129Sv/J strains, respectively. 73 Resting HR in rats is 330-480 bpm. 73 In Sprague-Dawley rats, HR is higher in female animals and is influenced by stress and group/single housing. 74 Seizures, both prolonged or repeated, have been reported to prolong cardiac QT intervals and increase the susceptibility to arrhythmias. 
There has been a renewed interest in investigating the impact of seizures and epilepsy on cardiovascular and autonomic function in preclinical models in order to understand the pathophysiologic mechanisms of SUDEP. An often overlooked aspect that is gaining considerable attraction recently is blood pressure. Blood pressure, and other autonomic function, is affected by seizures, and these effects may be associated with increased SUDEP risk. 70, 76 Blood pressure is readily measurable in patients, can relatively easily be measured in rodent models, and may provide important clues for assessing the risk of SUDEP.
Measurement of blood pressure
Specific methods:
• Tail cuff measurement in restrained animals: Rats or mice are placed in a mechanical restraining device with the tail exposed and accessible. The tail cuff is placed around the tail and attached to a commercial tail cuff blood pressure system (e.g., Hatteras, Inc; Visitech Systems). Typically a number (commonly 10) of blood pressure readings are taken over the sampling period and the average is recorded. 77 Tail cuff measurement has the advantage of allowing sampling in noninstrumented animals. The disadvantage is that the animals need to be restrained for accurate measurements. Therefore, this is more difficult to use in animals having unpredictable spontaneous seizures but can be useful with certain acute seizure induction models. 78 • Telemetry in freely moving animals: Telemetry has the advantage of allowing blood pressure sampling in awake and freely moving animals. This is especially appropriate for models in which animals are having spontaneous seizures, or in settings where animals will be subjected to recurrent, induced seizures. The disadvantage is that this requires surgical instrumentation of the animals. For measurement by telemetry, the telemeter and blood pressure leads must first be implanted. For implantation of a telemetry device in the femoral artery of a rat and into the aortic arch of a mouse, see Appendix S2 and Refs. 79, 80.
Sampling telemetry signals. Depending on the system used, animal cages are either placed directly on top of a telemetry receiver or placed near the receiver. A common approach is to sample each transmitter at 500 Hz for 10 s once every minute, and then calculate 10 min averages of blood pressure (i.e., systolic, diastolic, mean arterial pressure, and pulse pressure, etc.). A variety of software packages are available for sampling, recording, and analyzing blood pressure data.
Analysis and interpretation of the parameters that can be determined
• Systolic pressure • Diastolic pressure • Pulse pressure • Mean arterial pressure • With the telemetry methods, cardiac measures including heart rate, heart rate variability, and cardiac intervals such as P-R interval and Q-T interval can often also be obtained with the same telemetry device/receiver.
Measurement of blood pressure in anesthetized animals
For short-term experiments, isoflurane is frequently used for anesthesia in studies with mice. This volatile anesthetic compound has only moderate cardiodepressive effects compared to injectable agents. A 1.5% dose level of isoflurane was shown to yield stable blood pressure, heart rate, and cardiac output levels comparable to those recorded in the conscious state, or to decrease only slightly. 81 When nonvolatile anesthetics such as urethane, sodium pentobarbital, or the ketamine/xylazine mixture are used, heart-functionrelated parameters decrease, with the greatest effects recorded for the ketamine/xylazine mixture. 82 It therefore appears preferable to use isoflurane over nonvolatile anesthetics if anesthesia is required (Figs. 4 and 5) .
Blood sampling and testing
[File name: 6 CRF Module -blood testing.docx; 6 Blood Testing CDE Chart.xlsx]
It is the researcher's responsibility to select the appropriate sampling method for their goal as well as to obtain sufficient training in the technique to get valid samples. For more information see https://www.nc3rs.org.uk/our-re sources/blood-sampling. 83 
Rationale
Seizure events are often associated with a wide array of physiologic changes that can be measured in blood. Blood sampling easily provides material for the analysis of the consequences of seizures such as metabolic changes, lactate accumulation, inflammation markers, and genetic analysis. Blood can be collected in various ways 83 to determine a wide variety of substances present in blood, ranging from cells, proteins, blood gases, small RNAs, and the concentration of antiepileptic drugs (AEDs) or test compounds. Furthermore, biomarker discovery research can be performed in experimental epilepsy models using blood, plasma, or serum 84 . See Fig. 6 for advantages and disadvantages of different methods. The following information is provided to facilitate the use of the CRF in Fig.  7 for data acquisition.
Equipment: Needles, collection tubes. Procedure: General laboratory animal guidelines include (see also Ref. 83):
• Too much blood collected at any single time may cause hypovolemic shock, physiologic stress, and even death. If smaller volumes are collected too frequently, anemia may result.
• As a general rule, 10% of the total blood volume can be collected at one time every 2-4 weeks or 1% at intervals of 24 h or more. Total blood volume can be calculated as approximately 7.5% of body weight.
• The estimated volume at exsanguination is approximately half of the total blood volume.
• For repeated blood sampling, use aseptic techniques.
• To achieve vasodilation effects in rodents, it is helpful to warm the entire animal and/or to put the tail in warm water (38°C for 0.5-2 min) when blood withdrawal from the tail vein is planned.
• The choice of anesthetics is an important consideration when collecting blood from rodents due to the potential effects of the anesthetic agent on blood constituents, such as metabolites. General guidelines for blood collection in the rat (see also Ref. 82):
• The approximate blood volume of a rat is 64 ml/kg. For a 400 g rat this is equivalent to 25.6 ml.
• Single sampling: Without fluid replacement, the maximum blood volume that can be safely removed for a single-time sample is 10% of the total blood volume or 64 ml/kg. For a 400 g rat, this is equivalent to 2.5 ml.
• Multiple sampling: If it is necessary to take multiple samples, smaller blood volumes should be drawn, maximum <1% of the total blood volume (= 0.25 ml) in 24 h. For repeated blood collection, fluid replacement does not allow for a larger blood volume or more frequent blood collection.
• Exsanguination: Approximately half of the total blood volume can be collected at exsanguination. This is equivalent to 32 ml/kg or about 13 ml for a 400 g rat. General guidelines for blood collection in the mouse (see also Ref. 83):
• The approximate blood volume of a mouse is 77-80 ll/g. For a 25 g mouse this is equivalent to 1.9-2.0 ml.
• Single sampling: Without fluid replacement, the maximum blood volume that can be safely removed for a single-time sample is 10% of the total blood volume or 8 ll/g. For a 25 g mouse, this is equivalent to~200 ll. With fluid replacement, up to 15% of the total blood volume or 12 ll/g can be removed, that is, 290-300 ll. Generally, the fluid used as replacement should be warmed and given subcutaneously.
• Multiple sampling: If it is necessary to take multiple samples, smaller blood volumes should be drawn. The maximum blood volume that may be drawn per 24 h is less than 1% of the total blood volume, or 10 ll.
• Exsanguination: Approximately half of the total blood volume can be collected at exsanguination. This is equivalent to 40 ll/g or about 1 ml for a 25 g mouse. If the animal will be killed immediately before or after the blood collection:
• Trunk blood (to collect up to 2-6 ml of whole blood for a rat, up to 1 ml for a mouse). Collect blood directly from the trunk, after decapitation, without touching the animal with the collection tube. This approach allows the collection of large amounts of whole blood, but blood may be mixed with tissue fluids.
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• Intracardiac withdrawal (to collect up to 2-6 ml of whole blood for a rat, up to 1 ml for a mouse). The blood will be collected from the heart. For additional technical details, see Appendix S2 and Ref. 83 . If the animal will not be killed after the blood collection:
• Lateral saphenous vein withdrawal (no anesthesia required). Rat: Up to 0.2 ml may be taken for a single sample, which can usually be repeated at 2-week intervals without disturbance of the hematologic status. Alternatively, multiple smaller samples (e.g., 0.02 ml daily) may be obtained, taking into account the limits on total sample volume.
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Mouse: Up to 0.15 ml for a single sample; this can usually be repeated at 2-week intervals without disturbance to the hematologic status. Alternatively, multiple smaller samples (e.g., 0.01 ml daily) can be withdrawn, taking into account limits on sample volume. 85 There should not be more than 3 attempts to collect blood. Continuous sampling should be avoided and collecting more than 4 samples in a day (24- This procedure can be used for venous or arterial blood withdrawal only, 86, 87 but can also be used in combination with venous drug administration to determine pharmacokinetics of AEDs.
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• Orbital plexus This method should rather be used in anesthetized animals, especially in a seizure or epilepsy model, since it generates a large amount of stress that might itself generate seizures. In case animals are not anesthetized, usually before sampling a local anesthetic is dropped into the eye (e.g., 2% tetracaine). Rat: Up to 4 ml blood can be collected with recovery; 4-10 ml nonrecovery. It is recommended that only one sample be taken. Mouse: Up to 0.2 ml blood can be collected with recovery; up to 0.5 ml nonrecovery. It is recommended that only one sample be taken. • Retromandibular venous plexus This procedure allows collecting up to 300 ll of whole blood in mice, and care needs to be taken to limit as much as possible the volume to the allowed amounts described above. Please note that it can be difficult to restrict the blood flow, especially if the mouse is conscious, and if more than 500 ll of blood is withdrawn in a mouse, euthanasia must be considered. For additional details, see Appendix S2 and Ref. 89 plus Ref. 90 indicating the level of stress generated in animals by these repeated samplings and other laboratory routines.
Analysis and interpretation
Samples can be used for various blood tests. Select the appropriate method to handle the sample according to the test that will be used. Use whole blood as soon as possible for blood gas analysis or hematology. For RNA/protein analysis, centrifuge to separate plasma from whole blood within 1 h after whole blood collection using the following recommended parameters: 1300-1500 g for 10 min without a break at 4°C. For serum collection, let blood clot at room temperature for 1 h and centrifuge at 1300-1500 g for 10 min without the break at 4°C. Transfer the upper-phase into a new tube. To prevent platelet contamination, a second centrifuge step is needed (3000 g, 10 min, 4°C) before freezing. Freeze samples on dry ice and store aliquots at À70 or À80°C.
For additional reading, see Refs. 91-93.
Discussion
The purpose of this discussion is not to paraphrase all the critical aspects of physiology that have been detailed in the guidelines and CRF forms presented in this article. We chose to focus on a few points that are related to the topic of physiology but that were not developed in the previous sections.
The forms developed here are aimed at research in adult rodent epilepsy models but they can also be used for research in other rodent disease models. The forms that are presented in this article have been established for adult male rodents, which are most often used in experimental studies. However, some studies require the use of female animals, and it is critical to remember that although all physiologic parameters suggested in research on male rodents should also be measured in female rodents, some will differ with gender, especially with the estrous cycle in female rodents. 94 In most studies, the basal physiology of the animals is not considered by researchers, who rather focus on the validity and reproducibility of their models. In this paper, we developed forms for monitoring the physiologic status of animals when inducing epilepsy and during the course of the disease. Characterizing the physiologic status of animals that have undergone various procedures leading to the chronic pathology is critical. Mainly, the general status of the animals that have become epileptic should be assessed to establish valid criteria allowing inclusion of the animals in the groups studied, to increase homogeneity, but also to prevent unnecessary suffering of the animals.
An issue faced in animal research at the outset of a study the consideration of homogeneity of the groups, because the insertion of already sick animals (hypertensive or else) might strongly influence the outcome of the whole experimental group and introduce a bias in the experiment. Indeed, it is not unusual to find, for example, borderline diabetic or hypertensive animals in a given group of animals (AN, personal observations). It is clear that different genetic backgrounds will generate differences in sensitivity to and consequences of the epilepsy-generating insult.
The CDEs described in the previous sections were prepared for research in adult animals and are not fully valid for immature animals. Although the measurement of physiologic parameters listed here applies to immature animals as well, the equipment needed for assessing these parameters in immature rodents will need miniaturization, which at this point is not necessarily available for all types of measurements. Immature rodents are different from adult rodents, not only a miniature form of adult ones, and this will affect their responsiveness to seizures. It has been reported that immature rats are more or less sensitive than adult rats to convulsive agents, depending on the convulsant. 95, 96 In addition, at the same time, seizure spread is limited by brain maturation, especially in the limbic system, 97 and hence the consequences of seizures are also different in adult compared to immature rodents. 97, 98 There are periods of transient susceptibility to some types of seizures as in humans. This is the case in febrile seizures 99 or epileptic encephalopathies. 100 In addition, suckling immature rodents are in a state of natural ketosis, which might influence their sensitivity to seizures. 4 At this point, forms need to be developed for immature rodents with an adaptation to the size and immaturity.
The physiology CRFs and CDEs are also presented for other areas (pharmacology, EEG, and behavior; see other recent supplement articles), and we hope that researchers using the translational approach to epilepsy research will find them useful. Researchers are encouraged to use these forms as often as possible but, as stated in the introduction, depending on the type of model of seizure or epilepsy studied, the physiology, CDEs, and measurements detailed in the present manuscript will not all need to be used in every single experiment. The success of standardization of translational research will depend on the willingness of individual researchers to fill in the forms. The final aim of this whole process, that is, collecting all CDEs of the different approaches, is the hope of better comparison of the studies and performing homogeneous meta-analyses in order to reach stronger evidence of seizure-or treatment-induced changes that cannot always be concluded from individual studies. The ultimate hope is indeed to try to develop biomarkers and to find new treatments for epilepsy. Of note, the EPITARGET consortium has developed CDEs for other modules and has started to use a Research Electronic Data Capture (REDCap) database, in which actual data from preclinical studies can be registered online. 2, 101 Finally, to be able to develop these more standardized approaches, funds should be made available to publish and use interactive forms, maintain databases, and to take care that unpublished data are protected.
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